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YAP/Yorkie (Yki) is a transcriptional coactivator that controls organ size; dysregulation causes tumorigenesis
by stimulating cell proliferation and inhibiting apoptosis. The Hippo pathway restrains YAP/Yki activity, but it
remains unclear how cellular regulation at the plasma membrane influences the Hippo-YAP/Yki pathway.
Two papers in this issue on Developmental Cell, by Badouel et al. and Nishioka et al., address this question.Yes-Associated protein (YAP) is a potent
transcription coactivator that normally
promotes cell proliferation and inhibits
apoptosis. YAP is also a candidate onco-
gene and its expression and nuclear local-
ization are elevated in multiple human
cancers (Dong et al., 2007; Zhao et al.,
2007). Increased/ectopic expression of
YAP causes anchorage-independent and
serum-independent growth as well as
epithelial-mesenchymal transition (EMT)
(Overholtzer et al., 2006; Zhao et al.,
2007). In mice, spontaneous amplification
of YAP cooperates with myc to promote
liver tumor growth (Zender et al., 2006),
and transgenic overexpression of YAP
dramatically increases liver size and even-
tually causes liver tumors (Camargo et al.,
2007; Dong et al., 2007). Therefore, ample
evidence supports a role of YAP in organ
size control and tumorigenesis.
Obviously, as such a strong growth
promoter, YAP activity has to be tightly
regulated in order to avoid pathological
processes like hypertrophy and cancer.
How is YAP activity restricted? Drosophila
genetic studies and mammalian biochem-
ical analyses have revealed that the core
of the Hippo (Hpo) pathway is a kinase
cascade starting from the Ste20 family
kinase Hpo in association with a scaffold
protein Salvador (Sav) (reviewed by Edgar,
2006) (Figure1). TheHpo-Savkinasephos-
phorylates and activates the NDR family
kinase Warts (Wts), which interacts with
another adaptor protein Mats. Yki, the
Drosophila YAP homolog, was identified
as a Wts-interacting protein inhibited by
Wts and functioning downstream of theHpo pathway. All these proteins, including
MST1/2 (Hpo homolog), WW45 (Sav
homolog), Lats1/2 (Wts homolog), MOB1
(Mats homolog), and YAP (Yki homolog)
arehighlyconserved inmammals (Figure1).
At the end of the cascade, phosphorylation
of YAP by Lats results in 14-3-3 binding to
YAP and retaining it in the cytoplasm,
thus separating YAP from its transcription
factor partners such as Tead (Figure 1)
(Dong et al., 2007; Zhao et al., 2007).
Signals upstream of the Hpo pathway
core components, on the other hand, are
much less clear. Expanded (Ex) andMerlin
(Mer), two ezrin/radixin/moesin (ERM)
family cytoskeleton-related proteins, were
placed upstream of the Hpo pathway
mainly by Drosophila genetic study,
though biochemical evidence is elusive
(Hamaratoglu et al., 2006). In this issue
of Developmental Cell, McNeill and her
colleagues reported an unexpected
finding that Ex directly interacts with and
inhibits Yki (Badouel et al., 2009). This
interaction was identified by affinity purifi-
cation of Ex-interacting proteins; the Yki-
Ex interaction is nearly stoichiometric.
Further characterization showed that
binding is mediated by the WW domains
of Yki and thePPxYmotifs of Ex. This inter-
action is suggested to keepYki in the cyto-
plasm. The notion of Ex directly inhibiting
Yki is further supported by the observation
thatExoverexpressioncanpartially rescue
the overgrowth induced by the loss of
Wts. However, Ex overexpression did not
induce apoptosis in a wts mutant back-
ground, suggesting that blocking Yki
functions in cell survival are more strictlyDevelopmental Cell 1Hpo/Wts dependent, as proposed by
previous genetic studies. Further studies
are needed to determine which mecha-
nism (Ex directly binds to Yki versus Ex
signals through Hpo to Yki) is primarily
responsible for the inhibitory role of Ex on
Yki. As modeled in the report, the WW
domain of YAP/Yki should have inhibitory
function. However, WW domains of YAP/
Yki have been shown to be required for
YAP/Yki function in promoting cell prolifer-
ationandoncogenic transformation in vitro
and sustaining tissue overgrowth in vivo.
To reconcile these observations, one may
propose that the WW domains have dual
roles in mediating the binding of YAP/Yki
inhibitory components in the cytoplasm
and positive target transcription factors in
the nucleus. Notably, there is no obvious
Ex ortholog in mammals. Mammalian
FRMD1 and FRMD6 contain sequences
homologous to the N-terminal FERM
domainofEx,but lack theentireC-terminal
domain, which harbors the PPxY motifs
required for interaction with Yki, raising
the question of whether such a direct re-
gulation of Yki by Ex is conserved for
mammalian YAP.
Also in this issue of Developmental
Cell, an article by the Sasaki lab (Nishioka
et al., 2009) demonstrated that the Hpo
pathway, presumably by sensing cell-cell
contact, regulates YAP-Tead4 activity to
specify trophectoderm (TE) lineage during
mouse blastocyst development. The Hpo
pathway was reported to inhibit YAP in
response to increased cell density in cell
culture, mediating the cell contact inhibi-
tion phenomenon (Zhao et al., 2007). This6, March 17, 2009 ª2009 Elsevier Inc. 321
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PreviewsFigure 1. The Hippo Pathway in Drosophila and Mammals
Corresponding components in Drosophila and mammals are shown in the same color. Dashed arrows indicate unknown biochemical mechanism and question
marks denote unknown or uncertain components.report provides in vivo evidence to support
thehypothesis thatYAP is regulatedbycell
contact. During blastocyst formation, YAP
localizes in the nucleus of the outer cells
and in the cytoplasm of the inner cells in
a Lats-dependent manner, which is remi-
niscent of YAP phosphorylation by Lats
and 14-3-3-mediated cytoplasmic reten-
tion in cultured cells in vitro. Nishioka
et al. further demonstrated that the cyto-
plasmic localization of YAP in inner cells
is due to cell-cell contact because disrup-
tion of adherens junctions by an E-cad-
herin-neutralizing antibody brought YAP
back to nucleus. Moreover, fusion of
multiple blastomeres reprograms YAP
localization, as all the cells inside of the
chimera, of which some were originally
on the surface before fusion, now show
a cytoplasmic YAP localization. This study
further supports that cell-cell contact
generates a ‘‘positional cue’’ to modulate
YAP localization via the Hpo pathway in
vivo. However, the key molecule sensing
the positional cue is still elusive. Is it Fat
and its ligand or does something else
provide the cue? This is surely a key ques-
tion in theHpopathwayfieldand this report
provides a good in vivo model to address
this question.322 Developmental Cell 16, March 17, 2009In the same report, the authors demon-
strated that the active YAP in the outer
cells of a blastocyst activates Tead4 to
sustain expression of Cdx2 and other TE
markers. Thus, YAP-Tead4 specifies the
TE lineage as opposed to the inner cell
mass (ICM) from which embryonic stem
cells derive. These data indicate that the
Hpo pathway can be used not only to
control cell growth and survival, but also
to confer spatial pattern on embryonic
tissues. Indeed, this mechanism provides
the key stimulus that distinguishes
extraembryonic TE from the embryonic
ICM—arguably the most important devel-
opmental decision in mammals. Interest-
ingly, YAP-Tead has also been shown to
expand progenitor cell populations (Cao
et al., 2008). YAPoverexpression expands
multipotent undifferentiated progenitor
cells in mouse intestine (Camargo et al.,
2007), and TAZ, a YAP paralog, has also
been shown to modulate mesenchymal
stem cell differentiation and maintain
stem cell self-renewal. Therefore it will
also be very interesting to further explore
whether the Hpo pathway functions in
the specification, self-renewal, and differ-
entiation of stem cell lineages during
development.ª2009 Elsevier Inc.REFERENCES
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